Information Provided By: 
Fly News Breaks for February 24, 2017
SPLK
Feb 24, 2017 | 07:49 EDT
Canaccord analyst Richard Davis said he would be an aggressive buyer of Splunk shares on a pullback after the company materially beat revenues, earnings and cash flow expectations. Davis said he strongly recommends buying Splunk at current levels, reiterated his Buy rating and raised his price target to $75 from $70 on the shares.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
